| Title | Geography | Industry | ||||
|---|---|---|---|---|---|---|
| Alzheimer's Studies Fail to Meet Primary Goals, Claims Roche | Product Indicators | United States | Healthcare | Nov 2022 | ||
| COVID-19 Test Kits Market | Market Sizing & Shares | Global | Healthcare | Apr 2022 | ||
| COVID-19 and Antiviral Pills | Other Industry Indicators | Global | Healthcare | Jan 2022 | ||
| Omicron Triggers Global Spike in COVID-19 Cases | Other Industry Indicators | Global | Healthcare | Jan 2022 | ||
| Number of ongoing Clinical Trials (for drugs) involving Diabetic Neuropathy by Phase | Other Industry Indicators | Germany | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Achromatopsia by Phase | Other Industry Indicators | Canada | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Recurrent Medulloblastoma by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Neck Pain (Cervicalgia) by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Acromegaly by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Sezary Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Uveal Melanoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Short Bowel Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Presbyopia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Anaplastic Astrocytoma by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Epidermolysis Bullosa by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hairy Cell Leukemia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Essential Tremor by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Merkel Cell Carcinoma by Phase | Other Industry Indicators | Hungary | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Astrocytoma by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Ulcerative Colitis by Phase | Other Industry Indicators | Greece | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Anosmia by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Obesity by Phase | Other Industry Indicators | Serbia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Atherosclerosis by Phase | Other Industry Indicators | Germany | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hidradenitis Suppurativa by Phase | Other Industry Indicators | Poland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Peanut Allergy by Phase | Other Industry Indicators | Switzerland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Lung Cancer by Phase | Other Industry Indicators | Bosnia and Herzegovina | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Paroxysmal Nocturnal Hemoglobinuria by Phase | Other Industry Indicators | Poland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Nocturia by Phase | Other Industry Indicators | Taiwan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Trichotillomania by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Endometriosis by Phase | Other Industry Indicators | Belgium | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Tinnitus by Phase | Other Industry Indicators | Iran | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Gliosarcoma by Phase | Other Industry Indicators | Hong Kong | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Vitiligo by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Follicular Lymphoma by Phase | Other Industry Indicators | Luxembourg | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Lymphedema by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Squamous Cell Carcinoma by Phase | Other Industry Indicators | Romania | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Ophthalmology by Phase | Other Industry Indicators | Iran | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Tinea Capitis by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Rheumatoid Arthritis by Phase | Other Industry Indicators | United Kingdom | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pheochromocytoma by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pneumonia by Phase | Other Industry Indicators | Austria | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Thymic Carcinoma by Phase | Other Industry Indicators | Hungary | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Myasthenia Gravis by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Multiple Sclerosis by Phase | Other Industry Indicators | Hungary | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Prostate Cancer by Phase | Other Industry Indicators | Colombia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Gynecomastia by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Myopia by Phase | Other Industry Indicators | United Kingdom | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Ependymoma by Phase | Other Industry Indicators | Italy | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Skin Cancer by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Cystic Fibrosis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer